| Aug 29 |
Imunon files to sell up to 5M shares
|
| Aug 28 |
IMUNON to Host R&D Day on September 18th
|
| Aug 7 |
IMUNON to Hold Second Quarter 2024 Financial Results and Business Update Conference Call on Wednesday, August 14, 2024
|
| Aug 5 |
Peering Into Imunon's Recent Short Interest
|
| Jul 31 |
Imunon’s shares soar after IL-12 therapy success in Phase II trial
|
| Jul 31 |
IMUNON stock sinks as it looks to raise $10M via equity offering
|
| Jul 31 |
IMUNON Announces $10 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
|
| Jul 30 |
Sector Update: Health Care Stocks Edge Higher Late Afternoon
|
| Jul 30 |
Top Midday Gainers
|
| Jul 30 |
Nano-Cap IMUNON's Lead Candidate Shows Overall Survival Of Around 11 Months In Untreated Ovarian Cancer Patients
|
